Medartis Holding AG header image

Medartis Holding AG

MED

Equity

ISIN CH0386200239 / Valor 38620023

SIX Swiss Exchange (2026-10-05)
CHF 82.60+0.61%

Medartis Holding AG
UMushroom community rating:

star star star star star
5.00 1 votes No rating yet
NegativeNeutralPositive

About company

Medartis Holding AG is a Swiss medical‑device company that develops, manufactures and sells internal fixation implants, instruments and surgical systems for orthopaedic and trauma applications, with particular emphasis on fixation of small and medium bones such as those of the hand, wrist, foot/ankle and cranio‑maxillofacial areas. Its product range includes titanium and stainless‑steel plates, screws, locking systems and complementary surgical instruments, which it supplies to hospitals and surgeons through a network of subsidiaries and distributors across multiple regions; the business model is driven by product sales, aftermarket instrumentation and incremental R&D and regulatory work to broaden its clinical portfolio. As a publicly listed specialist in the orthopaedic-trauma segment, Medartis competes on product engineering, clinical support and targeted market coverage rather than on broad hospital consumable lines.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-3.84%1Y
9.84%3Y
-22.8%5Y

Performance

35.2%1Y
39.8%3Y
42.8%5Y

Volatility

Market cap

1237 M

Market cap (USD)

Daily traded volume (Shares)

7,734

Daily traded volume (Shares)

1 day high/low

59.6 / 51.2

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

1 votes
Performance:
starstarstarstarstar
5.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Peter Jürg Burkard
Switzerland, 26 Mar 2025
star star star star star
Scheint gut zu laufen.

EQUITIES OF THE SAME SECTOR

Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.93%CHF 348.90
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%CHF 116.48
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%CHF 53.08
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.89%CHF 91.50
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.06%CHF 79.25
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.36%CHF 243.60
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc Valor: 25337263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%USD 92.83
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.51%USD 23.58
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.45%USD 93.30
Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%USD 87.23